Previous 10 | Next 10 |
2023-10-13 15:47:48 ET Intercept Pharmaceuticals, which agreed to be sold to Sanofi ( NASDAQ: SNY ) late last month, quickly dropped 3% amid a new report from the European Medicines Agency. The study failed to show that Ocaliva was more effective than placebo (a dummy trea...
2023-10-11 10:00:00 ET With fears of a recession heightening on Wall Street, some might think it's best to steer clear from investing in equities. But as long-term investors know, holding shares of great companies through economic and market downturns is one of the keys to earning excellent...
2023-10-10 16:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Stagwell's (STGW) The Harris Poll Unveils First-of-its-kind Global Hemophilia Survey on the Daily Challenges for Patients, Caregivers, and Providers PR Newswire Findings reveal people living with hemophilia secretly carry the emotional burdens of the disease and report mental ...
2023-10-09 13:10:55 ET More on Bristol-Myers Squibb Company , Mirati Therapeutics Bristol-Myers' Mirati Takeover: Pharma Is Either Buying Crown Jewels Or A Dud Bristol-Myers: Out Of Favor (Rating Upgrade) Bristol-Myers Squibb: How Cheap Is Cheap Enough? ...
2023-10-05 15:26:42 ET More on GSK GSK: Strong Positioning And Trading At Historical Discount Merck Vs. GSK: The Game-Changer Race In Pharma Excellence GSK plc (GSK) BofA Global Healthcare Conference (Transcript) GSK to trim Haleon stake in over $1B share sal...
2023-10-05 15:13:58 ET More on Amgen Amgen Inc. (AMGN) Morgan Stanley 21st Annual Global Healthcare Conference 2023 (Transcript) Amgen Inc. (AMGN) Citi Global Healthcare Conference (Transcript) Amgen: Not An Investment Mistake, But It Was Better Before Amgen ...
2023-10-05 14:35:52 ET More on Mirati Therapeutics Mirati: Expansion Of Adagrasib With sNDA And Combination Studies Mirati Therapeutics, Inc. 2023 Q2 - Results - Earnings Call Presentation Mirati Therapeutics, Inc. (MRTX) Q2 2023 Earnings Call Transcript Mira...
2023-10-04 09:25:30 ET More on Moderna Moderna: Now That The COVID Party Is Over, What's Next? Moderna: Covid Curse Moving Beyond COVID: A Conservative Options Income Strategy For Moderna Updated COVID boosters to divide America Moderna to end m...
2023-10-04 06:31:10 ET More on Teva Teva considering potential sale of inflammatory bowel disease asset - Bloomberg Teva: Focus On Innovation And Growth Means The Times They Are A Changing The Mighty Teva Pharmaceutical: Unveiling A Bullish Scenario You Must Consider...
News, Short Squeeze, Breakout and More Instantly...
Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns. ...
2024-07-09 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...